3.212 articles found

Identification of platelet-derived biomarker in a cohort of Parkinson's disease

Dong Z, Xiang Y, Wang L, Ai Y, Du X, Sun Y, Lin Z, Liu T, Pan J, Deng J, Li P, Zhao Y, Li K, Sun Y, Zhang Z, Wang H, Li X, Yan Y, Sun Y, Cheng O, Chen G.

Genes & diseases · 2026-04-02

Wavelet event-related EEG phase coherence as a discriminant biomarker of the cognitive status in Parkinson's and Lewy body disease.

Özdemir S, Akan A, Aktürk T, Yıldırım E, Helvacı Yılmaz N, Hanoğlu L, Babiloni C, Güntekin B.

Front Hum Neurosci · 2026-04-02

DOI: 10.3389/fnhum.2026.1696861PMID: 42003980

Neuroinflammation plays a crucial role in the pathogenesis of Parkinson's disease: a systematic review and meta-analysis of clinical and biomarker evidence.

Hu H, Wang M, Yang Y, Wei Z.

Neurol Sci · 2026-04-02

DOI: 10.1007/s10072-026-08963-zPMID: 41922829

Identification of platelet-derived biomarker in a cohort of Parkinson's disease.

Dong ZY, Xiang Y, Wang L, Ai Y, Du XY, Sun YY, Lin ZH, Liu TF, Pan JB, Deng JW, Li P, Zhao Y, Li K, Sun YC, Zhang ZF, Wang HY, Li XH, Yan Y, Sun YA, Cheng OM, Chen GJ.

Genes Dis · 2026-04-02

DOI: 10.1016/j.gendis.2026.102171PMID: 42894650

PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease models.

Albornoz EA, Mardon K, Bhalla R, Kumar V, Stimson DHR, Cowin G, Cui CS, Butler MS, Pelingon R, Gordon R, Coll RC, Schroder K, Halai R, MacLeod AM, Matthews K, Robertson AAB, Cooper MA, Woodruff TM.

Brain · 2026-04-01

DOI: 10.1093/brain/awaf372PMID: 41099134

Fronto-caudate and callosal microstructural alterations: unveiling multimodal MRI biomarkers in early Parkinson's disease.

Bernabéu-Sanz Á, Morales S, Naranjo V, Fernández E.

Br J Radiol · 2026-04-01

DOI: 10.1093/bjr/tqag024PMID: 41619801

Gut microbiota and SCFA biomarkers for early diagnosis of PD patients and differentiation of its motor subtypes.

Zhang P, Du J, Gao C, Liu J, Huang M, Li H, Shen X, Tan Y, Chen S, Huang P.

NPJ Parkinsons Dis · 2026-04-01

DOI: 10.1038/s41531-026-01332-9PMID: 41922387

Midbrain Energy Homeostasis Biomarker for Differential Diagnosis of Early-Stage Parkinson Disease: A <sup>1</sup>H and <sup>31</sup>P MRI Study.

Yu Q, Zhang Y, Huang P, Li Y, Liu P, Jin Z, Wang X, Zhang B, Weng J, Wu P, Haacke EM, Wiegers EC, Wijnen JP, Klomp DWJ, Haller S, Chen S, Yan F, He N.

Radiology · 2026-04-01

DOI: 10.1148/radiol.251533PMID: 41944724

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.

Arnaldi D, Mattioli P, Orso B, Raffa S, Lanfranchi F, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Montini A, Mayà G, Muñoz-Lopetegi A, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, De Verbizier D, Plazzi G, Antelmi E, Pizza F, Terzaghi M, Bossert I, Kulcsárová K, Garibotto V, Nicastro N, Lathuilière A, Bonanni L, Morbelli S, Roascio M, Arnulfo G, Pardini M.

Eur J Nucl Med Mol Imaging · 2026-04-01

DOI: 10.1007/s00259-026-07834-1PMID: 41917515

Multimodal Biomarker-Guided Deep Brain Stimulation Programming in Parkinson’s Disease: The DBSgram Framework

Melo P, Carvalho E, Oliveira A, Peres R, Soares C, Rosas M, Arrais A, Vieira R, Dias D, Cunha JP, Ferreira-Pinto MJ, Aguiar P.

· 2026-03-31

DOI: 10.64898/2026.03.29.26349663

Long non-coding RNAs in neurodegenerative diseases - Molecular mechanisms, liquid biopsy biomarkers, and therapeutic targets: A review.

Cheng Y, Qiu M, Yu Z, Tang X, Zhang J.

Biomol Biomed · 2026-03-31

DOI: 10.17305/bb.2026.13978PMID: 41919473

Identification and clinical validation of autophagy-related genes as potential biomarkers of Parkinson's disease and their correlation with immune infiltration.

Dong Z, Dai F, Xing N, Wu Q, Gao H, Kan P, Han Y, Cheng X, Wang Y, Feng X, Zhang B.

Clin Neurol Neurosurg · 2026-03-31

DOI: 10.1016/j.clineuro.2026.109425PMID: 41926904